Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
57 Leser
Artikel bewerten:
(0)

Avery Biomedical Devices appoints Dr. Anders Jonzon as Clinical Consultant

COMMACK, New York, Nov. 24, 2015 /PRNewswire/ -- Avery Biomedical Devices (ABD), manufacturer of the Avery Breathing Pacemaker System, is pleased to announce the appointment of Anders Jonzon, MD; Ph.D. as clinical consultant.

Photo - http://photos.prnewswire.com/prnh/20151124/290596

Dr. Jonzon is a Physiologist and consultant in neonatology and pediatric cardiology at Children's Hospital, Uppsala University, Uppsala and Children's Hospital, Karolinska, Stockholm, Sweden. From 1984-1986, he was a fellow at the Cardiovascular Institute (UCSF). His research has covered circulation, control of breathing and ventilator treatment.

Dr. Jonzon has more than 25 years' experience of phrenic nerve stimulation in children with CCHS (congenital central hypoventilation syndrome) and other diseases causing hypoventilation.

Linda Towler, CEO, states, "We are honored and delighted to have Dr. Jonzon join our team. His experience and expertise in evaluating and treating those with congenital central hypoventilation syndrome (CCHS) will be instrumental to the future success of ABD."

Dr. Jonzon states, "I will be happy to share my experiences to those interested in phrenic nerve stimulation as an alternative to ventilator treatment."

ABOUT BREATHING PACEMAKERS
An Avery Breathing Pacemaker is an implanted phrenic nerve or diaphragm stimulator. It consists of surgically implanted electrodes and receivers and an external transmitter which sends radio signals to the implants via flexible antennas that are secured over the receivers.

The Avery Breathing Pacemaker is the only diaphragm pacing system to have full premarket approval (PMA) from the US FDA and CE Marking privileges under the European Active Implantable Medical Device Directive for adult and pediatric use. Due to their high reliability and cost effectiveness, the Avery pacers are reimbursed by Medicare and most private and government insurance around the world.

To learn more about the benefits of the Avery pacers for those with a high spinal cord injury, central sleep apnea or diaphragm paralysis, please contact us by mail, phone or through our website.

CONTACT
Neil Grossman, Director of Sales
+1-631-864-1600, ext. 214
neil.grossman@averybiomedical.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.